Latest Quarterly Financial Reports | Takeda Investor Relations
Jan 30, 2025 · View Takeda Pharmaceutical Company Limited's most recent earnings results. Download statements and reports, and listen to earnings announcements.
Takeda Announces Strong First Half FY2024 Results and Raises …
Dec 31, 2024 · For more details about Takeda’s FY2024 Q3 YTD results, commercial progress, pipeline updates and other financial information, including key assumptions in the FY2024 forecast and management guidance as well as definitions of non-IFRS measures, please refer to Takeda’s FY2024 Q3 investor presentation (available at https://www.takeda.com ...
Takeda Delivers Strong Third-Quarter FY2024 Results; Raises Full …
OSAKA, Japan, January 30, 2025 -- (BUSINESS WIRE)--Takeda (TOKYO:4502/NYSE:TAK) today announced earnings results for the third quarter of fiscal year 2024 (nine months ended December 31, 2024)...
Takeda Announces FY2023 Q3 Results; On-track towards Full-Year ...
Feb 1, 2024 · Takeda (TSE:4502/NYSE:TAK ) today announced financial results for the third quarter of fiscal year 2023 (period ended December 31, 2023). Takeda remains on track towards its full-year Management Guidance at Constant Exchange Rate.
Takeda Delivers Strong Third-Quarter FY2024 Results; Raises Full
Dec 31, 2024 · Takeda (TOKYO:4502/NYSE:TAK) today announced earnings results for the third quarter of fiscal year 2024 (nine months ended December 31, 2024) showing continued advancement of its Growth & Launch Products, which delivered double-digit …
Takeda Delivers Strong Third-Quarter FY2024 Results, Raises Full …
Jan 31, 2025 · OSAKA, Japan - Takeda (TOKYO: 4502/ NYSE: TAK) today announced earnings results for the third quarter of fiscal year 2024 (nine months ended December 31, 2024) showing continued advancement of its Growth & Launch Products, which delivered double-digit growth of 14.6% at CER.. The company has upgraded its full year outlook for growth, reflecting strong year-to-date product performance and OPEX ...
Takeda Pharmaceutical Company Limited (TAK) Q3 2025 Earnings …
Jan 30, 2025 · Takeda Pharmaceutical Company Limited (NYSE:TAK) Q3 2025 Results Conference Call January 30, 2025 5:30 AM ETCompany ParticipantsChristopher O’Reilly - Head,...
Drugmaker Takeda's CEO Weber to step down, raises profit forecast
Jan 30, 2025 · Takeda Pharmaceutical said on Thursday its CEO Christophe Weber will retire after more than a decade at the helm of Japan's biggest drugmaker as the company upped its full-year profit outlook.
Japan's Takeda says Q3 profit slid 38%, trailing analyst estimates
TOKYO (Reuters) - Japan's biggest drugmaker Takeda Pharmaceutical posted third-quarter profits on Thursday that trailed analyst estimates, as the company continues a restructuring push. Operating ...
Financial Statements and Highlights | Takeda Investor Relations
Jan 30, 2025 · Takeda Delivers Strong Third-Quarter FY2024 Results; Raises Full Year Outlook, Forecasting Revenue and Core Operating Profit Margin Growth
- Some results have been removed